With the start of the new year and JP Morgan next week, it’s time to start planning your 2017 life science capital investment campaign. Here are… Read more
Nsight Barbara Nelsen on the business of science.
Rapid growth in the cell and gene therapy industry is driving the demand for more efficient and cost-effective manufacturing solutions. Last week, Cell and Gene… Read more
It’s no surprise that cell and gene therapies are a very hot topic in the biotech industry right now. But, did you know that right… Read more
In Part 1 of this series, we highlight what investors want to see in a company’s business plan and hear in the pitch in order… Read more
From seed stage through exit, convertible debt to reverse merger, funding strategies are critical for companies to secure the capital necessary for success. To help… Read more